Stay updated on Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows a new revision number (v3.5.4) replacing the previous v3.5.3, indicating a minor internal update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-05-18T05:54:33.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page metadata/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3” without changing the study’s substantive details.
    Difference
    0.1%
    Check dated 2026-04-26T15:47:52.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T14:23:27.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T20:32:45.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T12:52:12.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-02-13T12:59:10.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.